Engineered Tcells for pancreatic cancer treatment
نویسندگان
چکیده
منابع مشابه
Exploiting the Innate Antitumor Activity of Human γδ-TCells for the Treatment of Prostate Cancer
Purpose: We have previously identified a CD2 mediated, interleukin-12 dependent signalingpathway that inhibits activation induced cell death in mitogen stimulated human -T cells,permitting the large-scale expansion of these cells. Herein we report the innate antitumoractivity of expanded human V 9V 2 -T cells against human prostate cancer cells.Materials and Methods: Apoptosis r...
متن کاملAntimetabolite Treatment for Pancreatic Cancer
Pancreatic cancer is a deadly and aggressive disease. Less than 1% of diagnosed patients survive 5 years with an average survival time of only 4-8 months. The only option for metastatic pancreatic cancer is chemotherapy where only the antimetabolites gemcitabine and 5-fluorouracil are used clinically. Unfortunately, efforts to improve chemotherapy regimens by combining, 5-fluorouracil or gemcit...
متن کاملTreatment for Refractory Pancreatic Cancer
While gemcitabine-based regimens are currently accepted as the standard first-line treatment of patients with locally advanced or metastatic pancreatic adenocarcinoma, there is no consensus regarding treatment in the second-line setting. This review is an update from the 2011 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium regarding recent developments in the tre...
متن کاملAdjuvant treatment for pancreatic cancer.
Pancreatic cancer is the fourth leading cause of cancer deaths in both men and women. Surgical resection has been shown to be the only curable treatment available. Unfortunately only 20% of all patients diagnosed with pancreatic cancer are surgical candidates due to the aggressive biology of this disease. There is no clear consensus on what type of adjuvant therapy should be used for patients w...
متن کاملThoracoscopic Splanchnicectomy for Pain Control in Irresectable Pancreatic Cancer
Introduction : Severepain is a major problem in patients with unresectable pancreatic cancer. The goal of this study is to evaluate the effects of Thoracoscopic Splanchnicectomy (TS) on pain control in these patients suffering from unresectable pancreatic cancer. Methods:Between years 2000 to 2011, 20 patients suffering from unresectable pancreatic cancer underwent TS due to severe pain. They w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: HPB
سال: 2011
ISSN: 1365-182X
DOI: 10.1111/j.1477-2574.2011.00344.x